https://vettapharma.com/pharmaceutical-news/fda-accepts-takedas-entyvio-sbla-for-pediatric-ibd/ 2026-06-10T09:54:08Z VETTAPHARMA en FDA Accepts Takeda's ENTYVIO sBLA for Pediatric IBD 2026-06-10T08:00:00Z Blog https://vettapharma.com/pharmaceutical-news/sanofi-stops-phase-3-riliprubart-study-in-refractory-chronic-inflammatory-demyelinating-polyneuropathy/ 2026-06-10T09:55:27Z VETTAPHARMA en Sanofi Stops Phase 3 Riliprubart Study in Refractory chronic inflammatory demyelinating polyneuropathy 2026-06-10T08:00:00Z Blog https://vettapharma.com/pharmaceutical-news/fda-approves-lillys-ebglyss-lebrikizumab-for-every-8-week-dosing/ 2026-06-10T09:56:00Z VETTAPHARMA en FDA Approves Lilly's EBGLYSS (Lebrikizumab) for Every-8-Week Dosing 2026-06-10T08:00:00Z Blog https://vettapharma.com/pharmaceutical-news/fda-approves-europes-bemotrizinol-for-u-s-sunscreens/ 2026-06-10T09:56:41Z VETTAPHARMA en FDA Approves Europe's Bemotrizinol for U.S. Sunscreens 2026-06-10T08:00:00Z Blog https://vettapharma.com/pharmaceutical-news/sanofis-sarclisa-sc-wins-eu-approval-for-at-home-delivery/ 2026-06-09T08:52:44Z VETTAPHARMA en Sanofi's Sarclisa SC Wins EU Approval for At-Home Delivery 2026-06-09T10:00:00Z Blog https://vettapharma.com/pharmaceutical-news/gsk-to-acquire-nuvalent-for-10-6-billion-to-expand-lung-cancer-portfolio/ 2026-06-09T08:32:31Z VETTAPHARMA en GSK to Acquire Nuvalent for $10.6 Billion to Expand Lung Cancer Portfolio 2026-06-09T10:00:00Z Blog https://vettapharma.com/pharmaceutical-news/pfizer-highlights-pipeline-momentum-across-obesity-hemophilia-and-investor-outreach/ 2026-06-09T09:05:49Z VETTAPHARMA en Pfizer Highlights Pipeline Momentum Across Obesity, Hemophilia, and Investor Outreach 2026-06-09T10:00:00Z Blog https://vettapharma.com/pharmaceutical-news/novartis-to-showcase-rhapsido-data-at-eaaci-2026/ 2026-06-09T08:06:22Z VETTAPHARMA en Novartis to Showcase Rhapsido Data at EAACI 2026 2026-06-09T08:06:18Z Blog https://vettapharma.com/pharmaceutical-news/roche-nurix-partner-on-btk-degrader-bexobrutideg/ 2026-06-09T07:58:34Z VETTAPHARMA en Roche, Nurix Partner on BTK Degrader Bexobrutideg 2026-06-09T08:00:00Z Blog https://vettapharma.com/pharmaceutical-news/moderna-oxford-win-uk-clearance-for-lynch-syndrome-vaccine-trial/ 2026-06-09T08:04:00Z VETTAPHARMA en Moderna, Oxford Win UK Clearance for Lynch Syndrome Vaccine Trial 2026-06-09T08:00:00Z Blog https://vettapharma.com/pharmaceutical-news/lillys-foundayo-outperforms-oral-semaglutide-in-phase-3-diabetes-trials/ 2026-06-09T08:46:52Z VETTAPHARMA en Lilly’s Foundayo Outperforms Oral Semaglutide in Phase 3 Diabetes Trials 2026-06-09T08:00:00Z Blog